Home/Filings/4/0001127602-21-003255
4//SEC Filing

McCubbin Quentin 4

Accession 0001127602-21-003255

CIK 0001703647other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:55 PM ET

Size

5.1 KB

Accession

0001127602-21-003255

Insider Transaction Report

Form 4
Period: 2021-01-29
McCubbin Quentin
Chief Manufacturing Officer
Transactions
  • Award

    Stock Option

    2021-01-29+90,00090,000 total
    Exercise: $38.99Exp: 2031-01-28Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% on January 19, 2022, and in equal monthly installments on the same day of each month thereafter and will be fully vested and exercisable on January 19, 2025.

Issuer

Frequency Therapeutics, Inc.

CIK 0001703647

Entity typeother

Related Parties

1
  • filerCIK 0001842009

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:55 PM ET
Size
5.1 KB